Scanning electron micrograph of the coronary microvasculature of a mouse that has been treated with a small
molecule tyrosine kinase inhibitor of platelet - derived growth factor receptor beta.
Not exact matches
These events occur when specific extracellular
molecules bind to receptor proteins in the plasma membrane known as receptor
tyrosine kinases and heterotrimeric G - protein - coupled receptors.
To cite a few instances, polymerase chain reaction (PCR), a molecular method developed over three decades ago, has been widely applied in disease diagnosis, disease mechanism deciphering, and prognosis prediction; the elucidation of
tyrosine kinase activity in cancer cells has led to the development of novel drugs for cancer treatment; and the identification of proteins and genetic
molecules by molecular methods as biomarkers for disease diagnosis and prognosis has been drawing great interest.
AG490 is a small
molecule inhibitor that blocks several
tyrosine kinases including Jak2 (Gazit et al., 1991); Ruxolitinib is a small
molecule inhibitor that specifically suppresses Jak
kinases (Quintas - Cardama et al., 2010).
Investigated TAM family receptor
tyrosine kinase gene expression in response to small
molecule inhibitors in glioblastoma multiforme